Literature DB >> 8257295

Sequence analysis of hepatitis B virus DNA in immunologically negative infection.

S Preisler-Adams1, H J Schlayer, T Peters, F Hettler, W Gerok, J Rasenack.   

Abstract

It was previously demonstrated that the serum of some patients without immunological evidence of HBV infection contains the virus. Here we demonstrated by sequence analysis that the serum of such a patient contained a mixed HBV population. In comparison with HBV genomes of different genotypes twenty-two nucleotide variations were found in all clones sequenced in parallel. One nucleotide variation was identified within the enhancer I. Twelve of the twenty-two nucleotide variations caused altogether fifteen changes of amino acid sequence in known or predicted viral proteins. The proteins of the P open reading frame, which are most important for viral replication, were affected by nine amino acid substitutions. Three amino acid substitutions concerned the product of the X gene, a transcriptional transactivator of various viral and cellular promoters. Three mutations were only observed in some of the clones. One point mutation affected the direct repeats of the enhancer II. It occurred together with an 8 bp-deletion involving the C promoter region and the X gene. The third mutation was a single insertion, causing a fusion of the X and C gene. One or several of the identified mutations could be responsible for the diminished rate of replication and consequently for the low-titred, immunologically negative HBV infection.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8257295     DOI: 10.1007/bf01313777

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  47 in total

1.  The hepatitis B virus X-C fusion protein is unlikely to be produced by the mechanism of ribosomal frameshifting.

Authors:  S J Lo; L R You; Y H Lee
Journal:  Virology       Date:  1990-10       Impact factor: 3.616

2.  Polymerase gene products of hepatitis B viruses are required for genomic RNA packaging as wel as for reverse transcription.

Authors:  R C Hirsch; J E Lavine; L J Chang; H E Varmus; D Ganem
Journal:  Nature       Date:  1990-04-05       Impact factor: 49.962

3.  Transmission of hepatitis B from hepatitis-B-seronegative subjects.

Authors:  V Thiers; E Nakajima; D Kremsdorf; D Mack; H Schellekens; F Driss; A Goudeau; J Wands; J Sninsky; P Tiollais
Journal:  Lancet       Date:  1988-12-03       Impact factor: 79.321

4.  Mutational analysis of the hepatitis B virus P gene product: domain structure and RNase H activity.

Authors:  G Radziwill; W Tucker; H Schaller
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

5.  Liver-specific expression of hepatitis B virus is determined by the combined action of the core gene promoter and the enhancer.

Authors:  J Honigwachs; O Faktor; R Dikstein; Y Shaul; O Laub
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

6.  Complete nucleotide sequence of a hepatitis B virus, subtype adw2, and identification of three types of C open reading frame.

Authors:  S Preisler-Adams; H J Schlayer; T Peters; R Korp; J Rasenack
Journal:  Nucleic Acids Res       Date:  1993-05-11       Impact factor: 16.971

7.  Regulation of the hepatitis B virus gene expression by the enhancer element I.

Authors:  K Q Hu; A Siddiqui
Journal:  Virology       Date:  1991-04       Impact factor: 3.616

8.  Nucleotide sequence of a cloned hepatitis B virus genome, subtype ayr: comparison with genomes of the other three subtypes.

Authors:  H Okamoto; M Imai; M Shimozaki; Y Hoshi; H Iizuka; T Gotanda; F Tsuda; Y Miyakawa; M Mayumi
Journal:  J Gen Virol       Date:  1986-11       Impact factor: 3.891

9.  Active hepatitis B virus replication in the presence of anti-HBe is associated with viral variants containing an inactive pre-C region.

Authors:  S P Tong; J S Li; L Vitvitski; C Trépo
Journal:  Virology       Date:  1990-06       Impact factor: 3.616

10.  Hepatitis B virus X protein is not central to the viral life cycle in vitro.

Authors:  H E Blum; Z S Zhang; E Galun; F von Weizsäcker; B Garner; T J Liang; J R Wands
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

View more
  6 in total

1.  A mutation of the start codon in the X region of hepatitis B virus DNA in a patient with non-B, non-C chronic hepatitis.

Authors:  Kiyotaka Fujise; Keiko Tatsuzawa; Midori Kono; Sadayori Hoshina; Akihito Tsubota; Minoru Niiya; Yoshihisa Namiki; Norio Tada; Hisao Tajiri
Journal:  World J Hepatol       Date:  2011-02-27

2.  A new hepadnavirus endemic in arctic ground squirrels in Alaska.

Authors:  P Testut; C A Renard; O Terradillos; L Vitvitski-Trepo; F Tekaia; C Degott; J Blake; B Boyer; M A Buendia
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

3.  Type, prevalence, and significance of core promoter/enhancer II mutations in hepatitis B viruses from immunosuppressed patients with severe liver disease.

Authors:  S Günther; N Piwon; A Iwanska; R Schilling; H Meisel; H Will
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

4.  Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen.

Authors:  H Okamoto; F Tsuda; Y Akahane; Y Sugai; M Yoshiba; K Moriyama; T Tanaka; Y Miyakawa; M Mayumi
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

5.  Characterization of unusual escape variants of hepatitis B virus isolated from a hepatitis B surface antigen-negative subject.

Authors:  S Grethe; M Monazahian; I Böhme; R Thomssen
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

6.  Comparative analysis of CpG islands among HBV genotypes.

Authors:  Yongmei Zhang; Chenxiao Li; Yijun Zhang; Haoxiang Zhu; Yaoyue Kang; Hongyan Liu; Jinyu Wang; Yanli Qin; Richeng Mao; Yi Xie; Yuxian Huang; Jiming Zhang
Journal:  PLoS One       Date:  2013-02-22       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.